AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2020
Aug 11, 2020
34097_dirs_2020-08-11_0c87a425-e7d0-493e-8416-91e05539975e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emerald Bioscience, Inc. (EMBI)
CIK: 0001516551
Period of Report: 2020-08-07-05:00
Reporting Person: Emerald Health Sciences Inc. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-07-05:00 | Common Stock | S | 3000000 | $0.1 | Disposed | 123490167 | Direct |
Footnotes
F1: Transfer of shares in a private transaction to directors, employees and consultants.
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10